ArticleBMC neurology2026
A novel NSD2 pathogenic variant in a Chinese patient with Rauch-Steindl syndrome: a case report.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionRauch-Steindl syndrome (RSS) is a very rare autosomal dominant disorder caused by pathogenic variants in the NSD2 gene, characterized by dysmorphic facial features, prenatal and postnatal growth retardation, and variable developmental delay. CASE PRESENTATION: We report the case of a 16-month-old Han Chinese girl who presented with typical features of RSS, including prenatal and postnatal growth failure, low body mass index, global developmental delay, expressive language impairment, infantile feeding difficulties, and distinctive dysmorphic facies (triangular face, broad forehead, high anterior hairline, deep-set eyes, full cheeks, thin and high nasal bridge, thick lower lip vermilion). She also exhibited mildly increased muscular tone in the lower limbs, transient recurrent respiratory infections, and a persistent atrial septal defect (ASD). Whole-exome sequencing identified a novel de novo heterozygous nonsense variant, NSD2 (NM_001042424.3): c.1466 C > G (p.Ser489Ter), in exon 6 on chromosome 4, which was classified as pathogenic according to ACMG guidelines. Notably, the patient exhibited an ASD that persisted through follow-up beyond 31 months of age, a feature not previously documented in RSS.
conclusionsThus, we report a novel pathogenic NSD2 variant alongside the presence of ASD in this individual, a feature not previously documented in RSS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.